UPDATE 1-No early win for Sanofi, Regeneron cholesterol drug in study

Nov 17 (Reuters) - Sanofi and Regeneron Pharmaceuticals said on Thursday they would continue a large clinical outcomes study with their injectable cholesterol-lowering drug Praluent, confounding... [Source]

Origin: reuters.com

Category: hotStocksNews

Topics: study, Sanofi, confounding, Praluent, injectable cholesterol-lowering, outcomes, clinical, a large, continue, would, Regeneron Pharmaceuticals, (Reuters), cholesterol, Regeneron, early, UPDATE

Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/2OChUnpBAzM/sanofi-regeneron-pharms-cholesterol-idUSL8N1DI4MH